Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 247 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Group of Florida - Fort Myers Retina Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Boehringer Ingelheim
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists South / Sarah Cannon Research Institute — Cape Coral, Florida (6.3 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - Fort Myers South — Fort Myers, Florida (9.7 mi)
· Sponsor: R1 Therapeutics
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Florida Cancer Specialists - SOUTH - SCRI - PPDS — Fort Myers, Florida (9.7 mi)
· Sponsor: Hoffmann-La Roche
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Southwest General Healthcare Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Housey Healthcare ULC
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Southwest Florida Proton Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Proton Collaborative Group
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Florida Cancer Specialists - South ( Site 7001) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Peace River Cardiovascular Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Florida Cancer Specialists - South ( Site 7002) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Cape Coral, Florida (6.3 mi)
· Sponsor: Pfizer
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
GenesisCare USA - FGO — Fort Myers, Florida (9.7 mi)
· Sponsor: NRG Oncology
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Southwest Florida Pain Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: ReGelTec, Inc.
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Biliary Tract Cancer
Phase 3
Interventional 620 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 3
Interventional 40 participants sought
GC2402 Study Site 103 — Port Charlotte, Florida (23.7 mi)
· Sponsor: Grifols Therapeutics LLC
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Advance Retina Institute — Bonita Springs, Florida (25.0 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 736 participants sought
Florida Cancer Specialists- Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: BioNTech SE
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 400 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca